About Company
"We Create Quality Professional AI"
Founded in 2016 with the goal of completing forecasting intelligence technology.
Neurodigm is a company dedicated to developing the world's best prediction systems. It was established by a research team that created Korea's first artificial intelligence system.
After more than four years of research since its founding, the company successfully developed an AI prediction engine and applied the technology to healthcare and transportation sectors. This led to the launch of the world's first disease prediction and diagnosis platform(AITHENON) and a real-time AI traffic flow control system(AITOBAHN)
Founders
Youngnam Koh
Founder / CEO
Motorola global software division
(Shamberg, USA), Sr. researcher
Samsung Advanced Institute of Technology
– Design and development of AI character recognition system.
Commercialized AI technology for the first time in Korea
Master of Computer Engineering, Yonsei University
Wook Kim
Founder / CTO
R&D of AI prediction & AI vision system
Founded Virtual Tech (listed on KOSDAQ)
Samsung Advanced Institute of Technology
– Design and development of AI character recognition system
Commercialized AI technology for the first time in Korea
Master of Computer Engineering, KAIST
Advisory Group
Chulhwan Kim
CEO of Sky Therapeutics
MIKTA Leader, Ministry of Foreign Affairs
Vice President, Korea Angel Investment Association
Director, KAIST Development Foundation
KAIST Adjunct Professor / Doctor of Engineering
Younghwan Cho
NLP, Multimodal AI Expert / Deep NLP Research
CEO of Two Block AI
MyScript, France
AIRI Research Director
Doctor of Engineering, KAIST
Kibong Moon
Director, Korea Project Industry Association
Busan Blockchain Regulatory Free Zone Promotion Team Steering Committee Member
CEO of Korea Smart Certification / NOA ATS
KAIST Bachelor
Track Record
Neurodigm's artificial intelligence technology and commercialization
2024
Supply of AITOBAHN to Gyeongju City
Expansion of AITOBAHN market (Seoul metropolitan area, Gyeongsang region, etc.)
Release of AITOBAHN Ver. 2.0
Global market expansion of AITHENON AI health screening solution to Southeast Asia and other regions
Completion of AITHENON AI health screening solution development
2023
Supply of AITOBAHN to Busan City
Completion of clinicaltrials for chemotherapy suitability assessment on AITHENON
Supply of AITHENON to International St. Mary's Hospital
Release of AITHENON Ver. 3.0
Completion of performance testing for AITHENON AI health screening
Development and supply of AI traffic violation unmanned enforcement system
2022
Signed a business cooperation agreement with Deloitte Consulting, including investment rights
Launched AITOBAHN, wide-area traffic flow control solution
Completed AITHENON platform performance test related to arrhythmia classification, early detection of dementia, etc
2021
AITOBAHN selected as a regulatory sandbox smart demonstration project organized by the Ministry of Land, Intrastructure and Transport
Completed development of ND_Prophet technology-based traffic flow control solution AITOBAHN, and completed development of disease prediction/diagnosis platform AITHENON
Registered patent of ND_Prophet technology-based AITOBAHN
ND_Prophet Technology-based, selected as a Post-TIPS program
2020
Launched ND_Prophet and ND_Eye
Registered a patent related to ND_Prophet
Completed development of artificial intelligence prediction/analysis engine ND_Prophet
Completed development of artificial intelligence image recognition engine ND_Eye
KRW 2.3 billion, attracting pre-A investment
2016 ~ 2019
Based on artificial intelligence prediction/analysis technology, selected as TIPS program
Select as a patent support project for IP
Established with the goal of developing an artificial intelligence prediction & analysis system